Moreover, due to the uncertainty regarding downstream proteins of AKT/mTOR signaling pathway that play an antidepressant role in depression, further research is necessary to reveal the more precise antidepressant mechanism of NAc-DBS for its expanded clinical use. This evidence concerns the gene AKT1 and major depressive disorder.